SRSD107

DRUG4 trials

Sponsors

Sirius Therapeutics Co., Ltd.

Conditions

Coronary Artery Disease (CAD)Peripheral Arterial DiseaseThrombosisThrombusVenous Thromboembolism

Phase 1

A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants

CompletedNCT06116617

Sirius Therapeutics Co., Ltd.Thrombosis

Start: 2024-01-23End: 2025-04-30Updated: 2025-05-18

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects

CompletedNCT07655427

Sirius Therapeutics Co., Ltd.Thrombus

Start: 2024-03-29End: 2025-03-02Updated: 2026-06-17

Phase 2

A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

RecruitingNCT07140523

Sirius Therapeutics Co., Ltd.Venous Thromboembolism

Start: 2025-09-16End: 2026-10-31Target: 450Updated: 2026-01-15

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

RecruitingNCT07318155

Sirius Therapeutics Co., Ltd.Coronary Artery Disease (CAD), Peripheral Arterial Disease

Start: 2025-03-11End: 2028-12-01Target: 104Updated: 2026-04-29